Copy Number Variations of EphA3 Are Associated With Multiple Types of Hematologic Malignancies Fulltext Access 4 Pages 2011
Unusual Autoimmune Nonhematologic Complications in Chronic Lymphocytic Leukemia Fulltext Access 4 Pages 2011
Heterogeneity of Histological Transformation Events in Waldenström's Macroglobulinemia (WM) and Related Disorders Fulltext Access 4 Pages 2011
Matrix Metalloproteinase-8 Is Overexpressed in Waldenström's Macroglobulinemia Cells, and Specific Inhibition of this Metalloproteinase Blocks Release of Soluble CD27 Fulltext Access 4 Pages 2011
Post-Treatment Bone Marrow Residual Disease > 5% by Flow Cytometry Is Highly Predictive of Short Progression-Free and Overall Survival in Patients With Waldenström's Macroglobulinemia Fulltext Access 4 Pages 2011
Hepcidin Is Produced by Lymphoplasmacytic Cells and Is Associated With Anemia in Waldenström's Macroglobulinemia Fulltext Access 4 Pages 2011
Autologous Stem Cell Transplantation as a Care Option in Waldenström's Macroglobulinemia Fulltext Access 4 Pages 2011
CD138 Expression Helps Distinguishing Waldenström's Macroglobulinemia (WM) From Splenic Marginal Zone Lymphoma (SMZL) Fulltext Access 4 Pages 2011
CD30-Positive EBV–Associated Diffuse Large B-Cell Lymphoma Occurring After Immunosuppressive Therapy for T-Cell Prolymphocytic Leukemia Fulltext Access 4 Pages 2011
Large Vessel (Takayasu's) Arteritis in a Patient With Myelodysplastic Syndrome: Is There a Common Pathogenesis? Fulltext Access 4 Pages 2011
Alemtuzumab-Based Reduced-Intensity Conditioning Allogeneic Transplantation for Myeloma and Plasma Cell Leukemia – A Single-Institution Experience Fulltext Access 4 Pages 2011
Treatment, Rationale, and Study Design of TALISMAN Study: A Randomized Phase II Open-Label Study of Second-line Erlotinib Versus Intermittent Erlotinib Dosing With Docetaxel in the Treatment of Former-Smoker Men Affected by Recurrent Squamous Non–Small-Ce Fulltext Access 4 Pages 2011
Circulating MicroRNAs: Possible Prediction Biomarkers for Personalized Therapy of Non-Small-Cell Lung Carcinoma Fulltext Access 4 Pages 2011
Rationale for Treatment and Study Design of TAILOR: A Randomized Phase III Trial of Second-line Erlotinib Versus Docetaxel in the Treatment of Patients Affected by Advanced Non–Small-Cell Lung Cancer With the Absence of Epidermal Growth Factor Receptor Mu Fulltext Access 4 Pages 2011
Publications des équipes françaises de médecine d’urgence. Où en est-on depuis cinq ans ? Fulltext Access 4 Pages 2011
PRO: Systemic Therapy for All Endometrial Cancers Should be Paclitaxel Plus Carboplatin Fulltext Access 4 Pages 2011
Cancer pain and its relationship to systemic inflammation: An exploratory study Fulltext Access 4 Pages 2011
Yoga for persistent pain: New findings and directions for an ancient practice Fulltext Access 4 Pages 2011
Comparing patients' and clinician-researchers' outcome choice for psychological treatment of chronic pain Fulltext Access 4 Pages 2011
Considerations for extrapolating evidence of acute and chronic pain analgesic efficacy Fulltext Access 4 Pages 2011
Evaluation of combination antiemetic prophylaxis in high risk emetogenic patients undergoing thyroid surgery: A randomized double-blind study Fulltext Access 4 Pages 2011
Comparison between continuous posterior and lateral interscalene brachial plexus blockades for major shoulder surgery Fulltext Access 4 Pages 2011
Prevention of rocuronium injection pain in paediatrics: Ketamine versus midazolam? A prospective randomized double blind study Fulltext Access 4 Pages 2011
The Efficacy and Toxicity of Bevacizumab in Combination With Gemcitabine in Patients With Recurrent Ovarian Cancer Fulltext Access 4 Pages 2011
PRO: Patients With Metastatic/Recurrent Cervical Cancer Should be Treated With Cisplatin Plus Paclitaxel Fulltext Access 4 Pages 2011
CON: Patients at High Risk for Ovarian Cancer Should Not Undergo Routine Screening Fulltext Access 4 Pages 2011
PRO: Patients With Recurrent Ovarian Cancer Should be Treated With Antiangiogenic Agents in Combination With Chemotherapy Fulltext Access 4 Pages 2011
CON: Not All Patients With Endometrial Cancer With Extrauterine Disease Should Receive Chemotherapy After Any Indicated Surgery Fulltext Access 4 Pages 2011
PRO: Patients With Endometrial Carcinoma Involving Extrauterine Disease Should, After Any Indicated Surgery, Receive Chemotherapy Fulltext Access 4 Pages 2011
Essential Thrombocythemia and Multiple Myeloma: Two Rare Diseases in One Patient Fulltext Access 4 Pages 2011
Regression of Hodgkin Lymphoma After Discontinuation of a Tumor Necrosis Factor Inhibitor for Crohn's Disease: A Case Report and Review of the Literature Fulltext Access 4 Pages 2011
Outcome of Diffuse Large B-Cell Lymphoma in the United States Has Improved Over Time but Racial Disparities Remain: Review of SEER Data Fulltext Access 4 Pages 2011
High-Dose Therapy/Autologous Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Marginal Zone Non-Hodgkin Lymphoma Fulltext Access 4 Pages 2011
A Case of Acute Promyelocytic Leukemia Without RARα Rearrangement and Apparently Normal Cytogenetics Fulltext Access 4 Pages 2011
Multiple Myeloma Associated IgA Pemphigus: Treatment With Bortezomib- and Lenalidomide-Based Regimen Fulltext Access 4 Pages 2011
Pharmacological treatment of bacterial infections of the respiratory tract Fulltext Access 4 Pages 2011
From transduction to pain sensation: Defining genes, cells, and circuits Fulltext Access 4 Pages 2011
Site de soumission en ligne pour médecine palliative : une nouvelle étape Fulltext Access 4 Pages 2011
à propos d'un cas d'arrêt d'oxygénothérapie chez un malade agonique en détresse respiratoire Fulltext Access 4 Pages 2011
Control of acute pain in postoperative and post-traumatic situations and the role of the acute pain service Fulltext Access 4 Pages 2011